(1)
Artosi, F.; Lanna, C.; Gaeta Shumak, R.; Borselli, C.; Costanza, G.; Rivieccio, A.; Orsini, D.; Lambiase, S.; Diluvio, L.; Bianchi, L.; Campione, E. Tildrakizumab As a Potential Option for Early Psoriatic Arthritis in Patients With Metabolic Comorbidities and Psoriasis: A Case Series. Dermatol Pract Concept 2025, 15 (4), 5570. https://doi.org/10.5826/dpc.1504a5570.